Evidence map›Paper›PMID 30115998›Full record

ArticleMucosal immunology2018

Tuning of human MAIT cell activation by commensal bacteria species and MR1-dependent T-cell presentation.

Cihan Tastan, Ece Karhan, Wei Zhou, Elizabeth Fleming, Anita Y Voigt, Xudong Yao, Lei Wang, Meghan Horne, Lindsey Placek, Lina Kozhaya and 2 more

Abstract read
In one paragraph

Article in Mucosal immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Avoidance of MAIT cells is an essential determinant ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Mucosal-Associated Invariant T Cells in Rheumatic Diseases.Arthritis & rheumatology (Hoboken, N.J.) · 2026
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Liver transplant-facilitated CD161Nature communications · 2025
    Article
  17. Review
  18. Review
  19. Skin microbiome and dermatologic disorders.The Journal of clinical investigation · 2025
    Review
  20. MAIT cells: Conserved watchers on the wall.The Journal of experimental medicine · 2025
    Review

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Cihan TastanJackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA.
Ece KarhanJackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA.
Wei ZhouJackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA.
Elizabeth FlemingJackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA.
Anita Y VoigtJackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA.
Xudong YaoDepartment of Chemistry, University of Connecticut, Storrs, CT, 06269, USA.
Lei WangDepartment of Chemistry, University of Connecticut, Storrs, CT, 06269, USA.
Meghan HorneJackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA.
Lindsey PlacekJackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA.
Lina KozhayaJackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA.
Julia OhJackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA.
Derya UnutmazJackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA. Derya@mac.com.

Funding

Topological Mapping of Immune, Microbiota, Metabolomic and Clinical Phenotypes to Reveal ME/CFS Disease Mechanisms - Clinical Research ProjectU54NS105539 · NINDS · JACKSON LABORATORY · PI UNUTMAZ, DERYA · 2017 to 2022
$10.6M
Decoding Immunological perturbations during Chronic Fatigue SyndromeR01AI121920 · NIAID · JACKSON LABORATORY · PI UNUTMAZ, DERYA · 2016 to 2020
$3.3M
NIAID NIH HHS R01 AI121920NINDS NIH HHS U54 NS105539
6 · The paper itself

Abstract

Human mucosal-associated invariant T (MAIT) cell receptors (TCRs) recognize bacterial riboflavin pathway metabolites through the MHC class 1-related molecule MR1. However, it is unclear whether MAIT cells discriminate between many species of the human microbiota. To address this, we developed an in vitro functional assay through human T cells engineered for MAIT-TCRs (eMAIT-TCRs) stimulated by MR1-expressing antigen-presenting cells (APCs). We then screened 47 microbiota-associated bacterial species from different phyla for their eMAIT-TCR stimulatory capacities. Only bacterial species that encoded the riboflavin pathway were stimulatory for MAIT-TCRs. Most species that were high stimulators belonged to Bacteroidetes and Proteobacteria phyla, whereas low/non-stimulator species were primarily Actinobacteria or Firmicutes. Activation of MAIT cells by high- vs low-stimulating bacteria also correlated with the level of riboflavin they secreted or after bacterial infection of macrophages. Remarkably, we found that human T-cell subsets can also present riboflavin metabolites to MAIT cells in a MR1-restricted fashion. This T-T cell-mediated signaling also induced IFNγ, TNF and granzyme B from MAIT cells, albeit at lower level than professional APC. These findings suggest that MAIT cells can discriminate and categorize complex human microbiota through computation of TCR signals depending on antigen load and presenting cells, and fine-tune their functional responses.

Indexed as

Antigen PresentationAntigens, BacterialBacteroidetesCells, CulturedGenetic EngineeringHistocompatibility Antigens Class IHumansInterferon-gammaLymphocyte ActivationMacrophagesMicrobiotaMinor Histocompatibility AntigensMucosal-Associated Invariant T CellsProteobacteriaReceptors, Antigen, T-CellRiboflavinAntigens, BacterialHistocompatibility Antigens Class IInterferon-gammaMinor Histocompatibility AntigensMR1 protein, humanReceptors, Antigen, T-CellRiboflavinTumor Necrosis Factor-alpha

Identifiers

PMID30115998
PMCPMC6279574

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.